BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Primary liver cancer
1
Systemic treatment of liver cancer: Current status and future perspectives
7/25/2025 12:09:39 PM | Browse: 20 | Download: 59
2
Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for primary liver cancer undergoing trans-arterial chemoembolization
6/13/2025 1:39:36 PM | Browse: 28 | Download: 275
3
Clinical significance of immune cell and biomarker changes in liver cancer
5/30/2025 10:57:33 AM | Browse: 49 | Download: 253
4
Impact of Linggui Zhugan decoction on microwave ablation outcomes and recurrence in liver cancer
1/18/2025 8:12:10 AM | Browse: 58 | Download: 274
5
Diagnostic value of serum vascular endothelial growth factor and interleukin-17 in primary hepatocellular carcinoma
9/18/2024 11:53:48 AM | Browse: 97 | Download: 474
6
Unraveling the efficacy network: A network meta-analysis of adjuvant external beam radiation therapy methods after hepatectomy
1/25/2024 6:43:29 AM | Browse: 157 | Download: 770
7
Development and validation of a machine learning-based early prediction model for massive intraoperative bleeding in patients with primary hepatic malignancies
1/11/2024 6:17:31 AM | Browse: 230 | Download: 759
8
Impact of hepatectomy and postoperative adjuvant transarterial chemoembolization on serum tumor markers and prognosis in intermediate-stage hepatocellular carcinoma
12/27/2023 12:41:39 PM | Browse: 188 | Download: 937
9
Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer
12/12/2022 6:36:34 AM | Browse: 286 | Download: 858
10
Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer
9/16/2022 11:52:44 AM | Browse: 359 | Download: 958
11
Risk stratification of primary liver cancer
9/2/2022 6:17:50 AM | Browse: 455 | Download: 1356
12
Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer
9/2/2022 6:17:49 AM | Browse: 475 | Download: 1512
13
Socioeconomics and attributable etiology of primary liver cancer, 1990-2019
6/2/2022 12:11:47 PM | Browse: 575 | Download: 1925
14
Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan
11/24/2021 9:54:22 AM | Browse: 597 | Download: 1256
15
Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment
11/12/2021 11:22:24 AM | Browse: 590 | Download: 1168
16
Successful totally laparoscopic right trihepatectomy following conversion therapy for hepatocellular carcinoma: A case report
7/28/2021 1:52:02 AM | Browse: 709 | Download: 1656
17
Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements
6/25/2021 9:46:23 AM | Browse: 745 | Download: 1653
18
Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125
1/23/2021 5:21:26 AM | Browse: 569 | Download: 1772
19
Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells
9/4/2020 7:25:49 AM | Browse: 798 | Download: 1874
20
Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer
8/16/2018 11:54:24 AM | Browse: 1048 | Download: 2065
21
Incidence and mortality of primary liver cancer in England and Wales: Changing patterns and ethnic variations
9/3/2014 10:14:00 AM | Browse: 997 | Download: 1002
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345